Cover Image
市場調查報告書

金磚四國的感染疾病診斷市場預測

BRIC Infectious Diagnostics Market Outlook to 2021

出版商 GlobalData 商品編碼 347962
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
金磚四國的感染疾病診斷市場預測 BRIC Infectious Diagnostics Market Outlook to 2021
出版日期: 2015年10月01日 內容資訊: 英文 83 Pages
簡介

本報告提供金磚四國的感染疾病診斷市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 金磚四國的感染疾病診斷市場

  • 收益實際成果·預測
  • 類別比較:各收益
  • 收益實際成果
  • 收益預測
  • 企業佔有率:各收益

第4章 巴西的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第5章 俄羅斯的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第6章 印度的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第7章 中國的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第8章 金磚四國的感染疾病診斷市場上主要企業概要

  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare
  • Abbott Laboratories
  • Transasia Bio-Medicals Ltd.
  • bioMerieux S.A.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Alere Inc.
  • DiaSorin S.p.A
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Cepheid

第9章 感染疾病診斷市場開發中產品

第10章 附錄

圖表

目錄
Product Code: GDMECR0347DB

GlobalData's new report, "BRIC Infectious Diagnostics Market Outlook to 2021", provides key market data on the BRIC Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Infectious Diagnostics market.
  • Global corporate-level profiles of key companies operating within the BRIC Infectious Diagnostics market.
  • Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Infectious Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Infectious Diagnostics Market, BRIC

  • 3.1. Infectious Diagnostics Market, BRIC, Revenue ($m), 2007-2021
  • 3.2. Infectious Diagnostics Market, BRIC, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Infectious Diagnostics Market, BRIC, Revenue ($m), 2007-2014
  • 3.4. Infectious Diagnostics Market, BRIC, Revenue ($m), 2014-2021
  • 3.5. Infectious Diagnostics Market, BRIC, Company Share by Revenue ($m), 2014

4. Infectious Diagnostics Market, Brazil

  • 4.1. Infectious Diagnostics Market, Brazil, Revenue ($m), 2007-2014
  • 4.2. Infectious Diagnostics Market, Brazil, Revenue ($m), 2014-2021
    • 4.2.1. Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2014-2021
  • 4.3. Infectious Diagnostics Market, Brazil, Distribution Share by Revenue ($m), 2013-2014
  • 4.4. Infectious Diagnostics Market, Brazil, Company Share by Revenue ($m), 2014

5. Infectious Diagnostics Market, Russia

  • 5.1. Infectious Diagnostics Market, Russia, Revenue ($m), 2007-2014
  • 5.2. Infectious Diagnostics Market, Russia, Revenue ($m), 2014-2021
    • 5.2.1. Infectious Diagnostics Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Infectious Diagnostics Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2014-2021
  • 5.3. Infectious Diagnostics Market, Russia, Distribution Share by Revenue ($m), 2013-2014
  • 5.4. Infectious Diagnostics Market, Russia, Company Share by Revenue ($m), 2014

6. Infectious Diagnostics Market, India

  • 6.1. Infectious Diagnostics Market, India, Revenue ($m), 2007-2014
  • 6.2. Infectious Diagnostics Market, India, Revenue ($m), 2014-2021
    • 6.2.1. Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2014-2021
  • 6.3. Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 6.4. Infectious Diagnostics Market, India, Company Share by Revenue ($m), 2014

7. Infectious Diagnostics Market, China

  • 7.1. Infectious Diagnostics Market, China, Revenue ($m), 2007-2014
  • 7.2. Infectious Diagnostics Market, China, Revenue ($m), 2014-2021
    • 7.2.1. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 7.2.2. Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
  • 7.3. Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 7.4. Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014

8. Overview of Key Companies in BRIC Infectious Diagnostics Market

  • 8.1. F. Hoffmann-La Roche Ltd.
    • 8.1.1. Company Overview
  • 8.2. Siemens Healthcare
    • 8.2.1. Company Overview
  • 8.3. Abbott Laboratories
    • 8.3.1. Company Overview
  • 8.4. Transasia Bio-Medicals Ltd.
    • 8.4.1. Company Overview
  • 8.5. bioMerieux S.A.
    • 8.5.1. Company Overview
  • 8.6. Danaher Corporation
    • 8.6.1. Company Overview
  • 8.7. Bio-Rad Laboratories, Inc.
    • 8.7.1. Company Overview
  • 8.8. Qiagen N.V.
    • 8.8.1. Company Overview
  • 8.9. Alere Inc.
    • 8.9.1. Company Overview
  • 8.10. DiaSorin S.p.A
    • 8.10.1. Company Overview
  • 8.11. Becton, Dickinson and Company
    • 8.11.1. Company Overview
  • 8.12. Hologic, Inc.
    • 8.12.1. Company Overview
  • 8.13. Cepheid
    • 8.13.1. Company Overview

9. Infectious Diagnostics Market Pipeline Products

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Company Share Analysis
    • 10.1.5. Distribution Share Analysis
  • 10.2. GlobalData Consulting
  • 10.3. Contact Us
  • 10.4. Disclaimer

List of Tables

  • Table 1: Infectious Diagnostics Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Infectious Diagnostics Market, BRIC, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Infectious Diagnostics Market, BRIC, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Infectious Diagnostics Market, BRIC, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Infectious Diagnostics Market, BRIC, Company Share by Revenue ($m), USD Constant, 2014
  • Table 6: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Infectious Diagnostics Market, Brazil, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 11: Infectious Diagnostics Market, Brazil, Company Share by Revenue ($m), USD Constant, 2014
  • Table 12: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Infectious Diagnostics Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 15: Infectious Diagnostics Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Infectious Diagnostics Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Infectious Diagnostics Market, Russia, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 19: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 20: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 21: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 22: Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 23: Infectious Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 24: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 26: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 28: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 29: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 30: Infectious Diagnostics Market Pipeline Products

List of Figures

  • Figure 1: Infectious Diagnostics Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Infectious Diagnostics Market, BRIC, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Infectious Diagnostics Market, BRIC, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Infectious Diagnostics Market, BRIC, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Infectious Diagnostics Market, BRIC, Company Share (%) 2014
  • Figure 6: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Infectious Diagnostics Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 9: Infectious Diagnostics Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 10: Infectious Diagnostics Market, Brazil, Company Share (%) 2014
  • Figure 11: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Infectious Diagnostics Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Infectious Diagnostics Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Infectious Diagnostics Market, Russia, Company Share (%) 2014
  • Figure 16: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 17: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Infectious Diagnostics Market, India, Company Share (%) 2014
  • Figure 21: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 23: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 24: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 25: Infectious Diagnostics Market, China, Company Share (%) 2014
Back to Top